Is AIG's Chinese Expansion in Jeopardy?

Before you go, we thought you'd like these...
Before you go close icon

As insurance giant AIG tries to maintain its momentum and spark growth, it's been making big moves in China. But, with the country's economy slowing, and concerns of strict economic reforms ahead, investors may be concerned that AIG has made the wrong bet. In this video, Motley Fool contributor Jessica Alling explains why all may not be lost for AIG, and how investors should look ahead.

At the end of last year, AIG was the favorite stock among hedge fund managers. Have they identified the next big multi-bagger, or are the risks facing the insurance giant still too great? In The Motley Fool's premium report on AIG, Financials Bureau Chief Matt Koppenheffer breaks down the key issues that you need to know about if you want to successfully invest in this stock. Simply click here now to claim your copy, and you'll also receive a full year of key updates and expert analysis as news continues to develop.


{%video%}

The article Is AIG's Chinese Expansion in Jeopardy? originally appeared on Fool.com.

Fool contributor Jessica Alling has no position in any stocks mentioned, but you can contact her here. The Motley Fool recommends American International Group. The Motley Fool owns shares of American International Group and has the following options: Long Jan 2014 $25 Calls on American International Group. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners